Therefore, in order to evaluate the value of PLA1A expression as a diagnostic marker in the treatment of BRAF/NRAS-mutant melanoma, the expression of PLA1A in BRAF and NRAS mutant samples was evaluated through the use of the linear logistic regression in Fig. 2D,E, respectively. The gene discussed is NRAS; the disease is melanoma.